Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

NCT00386984 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT00386984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00386984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
Lead sponsor
University Hospital Freiburg
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1999
Completion date
February 28, 2003
Enrollment
108
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular